News
10-12-2010, 02:02 AM
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
More... (http://www.news-medical.net/news/20101012/First-presentation-of-anti-HER2-antibody-drug-conjugate-as-first-line-therapy-for-advanced-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20101012/First-presentation-of-anti-HER2-antibody-drug-conjugate-as-first-line-therapy-for-advanced-breast-cancer.aspx)